Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Base Year
Historical Year
Forecast Year
Hemostasis is the body’s reaction to heal an injury that caused bleeding in the first place. The capability of the body to heal itself plays a vital role in the survival of a person. The reaction is a combination of multiple processes coming together to heal a wound. The market for hemostasis is driven by the rising incidence of surgical procedures, new product launches developed using innovative materials and the rising prevalence of accidents on a global scale. Conditions like hemophilia and von Willebrand disease are driving the need for advanced hemostasis solutions, leading to increased R&D for better treatments.
Rising Surgical Procedures Contributing to Rising Demand for Hemostasis Management
The market growth can be attributed to the escalating number of surgeries across several fields including cardiovascular and trauma surgeries. As per the data published by the Annals of Thoracic Surgery Short Reports, the average cardiac surgical volume is around 123.2 surgeries per 100,000 population per year in high-income countries. Similarly, surgeries for other chronic diseases are increasing, creating a high demand for hemostasis agents, and stimulating market growth.
Increasing Approvals to Meet Rising Hemostasis Market Demand
The market growth is poised to be driven by the increasing FDA approvals, enabling the availability of multiple hemostasis solutions contributing to enhanced patient outcomes. For instance, in November 2023, Ethicon, a Johnson & Johnson MedTech company, announced the approval of ETHIZIATM, an adjunctive hemostasis solution that has been clinically proven to achieve sustained hemostasis in difficult-to-control bleeding situations. ETHIZIA™ Hemostatic Sealing Patch is comprised of unique synthetic polymer technology and is the first and only hemostatic matrix designed to be equally active and efficacious on both sides.
Additionally, in April 2024, Haemonetics Corporation, a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, announced the 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the TEG® 6s hemostasis analyzer system Global Hemostasis-HN assay cartridge. This new cartridge extends Haemonetics' TEG 6s viscoelastic testing capabilities to serve fully heparinized patients in adult cardiovascular surgeries/procedures and liver transplantation in both laboratory and point-of-care settings. This product launch is expected to assist physicians in improving hemostasis management for their patients, especially in critical situations like open heart and liver transplant surgeries and major trauma. The FDA clearance is also projected to make effective and efficient viscoelastic testing more accessible, contributing to market expansion.
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
Key Trends | Impact |
Technological Advancements | The market is experiencing growing adoption of point-of-care (POC) testing and automated devices, improving accuracy and speed in diagnosing and managing bleeding disorders. These advanced devices are poised to bring innovation to the hemostasis landscape. |
Product Launches Propelling Market Growth | One of the major market trends involves new product launches. For instance, in July 2024, Baxter International Inc., a global leader in advancing surgical innovation launched PERCLOT Absorbable Hemostatic Powder in the United States. PERCLOT is a passive, absorbable hemostatic powder designed to be used by patients with intact coagulation to address mild bleeding. New product launches are poised to fuel market growth, contributing to enhanced patient outcomes. |
Advanced Hemostatic Agents | With rising surgical procedures and trauma cases, the demand for advanced hemostatic agents, such as tissue sealants and fibrin adhesives, is increasing globally. Key players are developing novel products such as fibrin sealants, collagen-based agents, gelatin sponges, and synthetic sealants. These products offer rapid clotting and tissue adhesion properties, enhancing surgical outcomes. |
Growth in Minimally Invasive Surgeries | There is a growing preference for minimally invasive surgeries driven by its faster recovery times and reduced complications. With more minimally invasive surgeries being performed, specialised hemostatic products that aid in faster recovery and reduced blood loss are in higher demand. |
Market Breakup by Product Type
Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
Market Share Based on Application to Witness Substantial Growth
The market segmentation by application is categorised into general surgery, neurosurgery, vascular surgery, cardiovascular surgery, and others. The market share is dominated by general surgeries due to the high incidence worldwide. Hemostatic management plays a vital role in surgical procedures to control the blood flow and avoid excessive bleeding during and after the procedures. These hemostat agents have common applications in advanced surgical procedures that necessitate effective tissue-sealing agents to eliminate or reduce complications and result in improved patient outcomes. The similar nature of collagen-based hemostats to the collagen in the tissue makes them a preferred option to be used in these surgeries.
North America is dominating the market share by region due to the rising cases of excessive bleeding and the need to bring new solutions for hemostasis management. The market is poised to be driven by the presence of a robust healthcare infrastructure, enabling the availability of technically advanced management solutions. Further, the presence of some of the key players in the region is stimulating market growth. The region leads the hemostats market due to significant healthcare expenditure, and the presence of major pharmaceutical and medical device companies that are focused on bringing innovation into the market.
The region experiences a high volume of surgical procedures, and trauma cases, and also holds a significant share of the geriatric population contributing to increased demand for hemostatic products. Additionally, strong regulatory frameworks and rapid adoption of advanced medical technologies, such as minimally invasive surgical tools and point-of-care hemostasis testing, further fuel the market. The regional dominance is also attributed to the continuous focus on product innovation and widespread insurance coverage supporting growth in the market.
The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis and strategic initiatives by the leading players. The major companies in the market are as follows:
Medtronic PLC
Medtronic offers a range of hemostatic products, including advanced surgical sealants, topical agents, and mechanical haemostats. Its portfolio focuses on managing bleeding during surgeries, enhancing wound healing, and improving patient recovery through innovative medical technologies across cardiovascular, neuro, and general surgeries.
Johnson & Johnson Inc.
Johnson & Johnson, through its subsidiary Ethicon, provides a comprehensive portfolio of hemostatic products including SURGIFLO®, SURGICEL®, and EVARREST®. These products are designed to control bleeding in surgical settings, ensuring rapid hemostasis and improved patient outcomes across various surgical procedures.
Baxter International Inc.
Baxter is a key player in the hemostasis market, offering products like Floseal® and Tisseel®. These haemostatic agents are used in surgical procedures to control bleeding, combining biological and mechanical hemostasis for optimal surgical outcomes, supporting vascular, orthopaedic, and general surgery applications.
Pfizer
Pfizer's presence in the hemostasis market is primarily through its biologics division, offering recombinant clotting factors, such as BeneFIX®, for the treatment of haemophilia. The company focuses on therapies that enhance blood clotting for patients with clotting disorders, supporting both surgical and non-surgical applications.
BD
BD focuses on hemostasis through its range of vascular access devices, blood collection systems, and point-of-care diagnostics. Its products help manage blood flow, improve blood sampling, and enhance patient safety in various clinical settings, from surgery to emergency care.
Other key players in the market include B. Braun SE, Tricol Biomedical, Boston Scientific Corporation, Cura Medical, and Teleflex Incorporated.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us today for customized, data-driven solutions tailored to your unique requirements!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product Type |
|
Breakup by Application |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124